共 50 条
- [21] Efficacy and safety of BCMA-specific CAR T cell-based therapy in relapsed/refractory multiple myeloma patients with extramedullary disease CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S57 - S57
- [25] High-dimensional analysis of the CD8+T cell response in multiple myeloma JOURNAL OF IMMUNOLOGY, 2024, 212 (01):
- [28] Vγ9Vδ2 T cells expressing a BCMA-Specific chimeric antigen receptor inhibit multiple myeloma xenograft growth PLOS ONE, 2022, 17 (06):